Literature DB >> 2865675

Rapid reversal of carcinoid crisis with a somatostatin analogue.

L K Kvols, J K Martin, H M Marsh, C G Moertel.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 2865675     DOI： 10.1056/NEJM198511073131915

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

Review 1.  Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.

Authors:  Wouter W de Herder; Steven W J Lamberts
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

Review 2.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 3.  Management of carcinoid syndrome.

Authors:  A Saini; J Waxman
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

4.  Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis.

Authors:  E Roti; R Minelli; E Gardini; M Salvi; L Bianconi; L Balducci; A Manfredi; L E Braverman
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

5.  Failure of somatostatin or an analog to promote closure of end pancreatic fistulae.

Authors:  B M Miller; L W Traverso; P C Freeny; N N Abumrad
Journal:  Int J Pancreatol       Date:  1989-02

Review 6.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

7.  The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.

Authors:  J T Watson; N H Badner; M J Ali
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

Review 8.  The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.

Authors:  Mauro Cives; Jonathan Strosberg
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

9.  Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.

Authors:  Bart de Keizer; Maarten O van Aken; Richard A Feelders; Wouter W de Herder; Boen L R Kam; Martijn van Essen; Eric P Krenning; Dik J Kwekkeboom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-16       Impact factor: 9.236

10.  Update on management of midgut neuroendocrine tumors.

Authors:  Amir Mehrvarz Sarshekeh; Daniel M Halperin; Arvind Dasari
Journal:  Int J Endocr Oncol       Date:  2016-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.